Name
Osaühing Perearst Milvi Sild
Registry code
10853850
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.06.2002 (22)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
400 687 €
89 218 €
22%
3 138 €
(estimate is approximate)
188 260 €
3
Submitted
No tax arrears
47%
40%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Milvi Sild 27.03.1954 (70) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 24.04.2020 | 2020 30.06.2021 | 2021 27.05.2022 | 2022 10.03.2023 | 2023 24.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 245 262 € | 284 317 € | 313 483 € | 347 311 € | 400 687 € |
| Net profit (loss) for the period | 40 304 € | 68 268 € | 76 929 € | 60 133 € | 89 218 € |
| Profit Margin | 16% | 24% | 25% | 17% | 22% |
| Current Assets | 110 940 € | 132 972 € | 178 762 € | 176 218 € | 211 085 € |
| Fixed Assets | 16 262 € | 4 202 € | 7 615 € | 13 665 € | 11 492 € |
| Total Assets | 127 202 € | 137 174 € | 186 377 € | 189 883 € | 222 577 € |
| Current Liabilities | 18 978 € | 16 865 € | 21 397 € | 27 317 € | 34 317 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 108 224 € | 120 309 € | 164 980 € | 162 566 € | 188 260 € |
| Employees | 3 | 3 | 3 | 3 | 3 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 27 796.87 € | 22 982.69 € | 4 |
| 2023 Q4 | - | 21 325.13 € | 16 884.73 € | 5 |
| 2023 Q3 | - | 16 815.28 € | 14 781.82 € | 5 |
| 2023 Q2 | - | 11 720.36 € | 12 242.98 € | 4 |
| 2023 Q1 | - | 20 607.97 € | 17 394.01 € | 5 |
| 2022 Q4 | - | 18 154.01 € | 14 374.53 € | 5 |
| 2022 Q3 | - | 11 465.45 € | 11 959.33 € | 5 |
| 2022 Q2 | - | 21 863.14 € | 18 252.81 € | 5 |
| 2022 Q1 | - | 15 183.55 € | 15 837.69 € | 5 |
| 2021 Q4 | - | 12 595.56 € | 13 112.68 € | 5 |
| 2021 Q3 | - | 19 853.99 € | 15 456.53 € | 5 |
| 2021 Q2 | - | 10 278.67 € | 10 878.79 € | 4 |
| 2021 Q1 | - | 11 745.04 € | 12 406.35 € | 4 |
| 2020 Q4 | - | 18 854.17 € | 12 034.28 € | 4 |
| 2020 Q3 | - | 18 826.57 € | 14 533.92 € | 4 |
| 2020 Q2 | - | 10 022.53 € | 10 651.58 € | 4 |
| 2020 Q1 | - | 11 266.14 € | 11 926.4 € | 4 |
